Legislation signed by Gov. Rick Snyder on July 15, 2011, will require changes in the manner in which all retail establishments log the sale of pseudoephedrine products.
Senate Bill 333
, introduced by Sen. John Proos (R-St. Joseph), and House Bill 4749
, introduced by Rep. Amanda Price (R-Holland), were enacted to reduce the continued problem related to the illicit manufacture of methamphetamine. In spite of previous legislation enacted at both the state and federal level to curb methamphetamine abuse, it continues to rise, particularly in southwest Michigan. The adoption of this legislation is a further attempt to control the sale of pseudoephedrine (PSE), the precursor medication used in the manufacture of methamphetamine and to respond to similar legislation enacted in neighboring states.
Beginning Jan. 1, 2012, purchasers of medications containing ephedrine or pseudoephedrine will be required to produce an ID and have their names entered into a law enforcement database. Retailers will enter this information electronically into the National Precursor Log Exchange (NPLEx), which is administered by the National Association of Drug Diversion Investigators (NADDI). The legislation mandates that the retailer shall not be required to pay a fee for the utilization of the NPLEx system.
The NPLEx system is capable of generating a stop sale alert notifying the retailer that completion of the sale would result in the seller or purchaser violating the quantity limits set forth in the state regulations and the Federal Combat Methamphetamine Act of 2005. The previous quantity limits prohibited the sale of pseudoephedrine to two packages, or 48 tablets or capsules, of any product described in the section. The new limitations are consistent with federal regulations limiting the sale to not more than 3.6 grams of ephedrine or pseudoephedrine alone or in a mixture within a single calendar day, and not more than nine grams of ephedrine or pseudoephedrine alone or in a mixture within a 30-day period.